Sage Therapeutics Inc. sell StockNews.com
Start price
20.04.24
/
50%
€12.32
Target price
20.04.25
-
Performance (%)
-46.75%
End price
21.04.25
€6.56
Summary
This prediction ended on 21.04.25 with a price of €6.56. StockNews_com correctly predicted massive losses of -46.75% for Sage Therapeutics Inc.. StockNews_com has a follow-up prediction for Sage Therapeutics Inc. where he still thinks Sage Therapeutics Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1.659% | 1.586% | 18.113% |
| iShares Nasdaq 100 | 0.381% | 1.900% | 8.877% |
| iShares Nikkei 225® | 2.102% | -1.377% | 13.281% |
| iShares S&P 500 | 0.221% | 1.258% | 3.556% |
Comments by StockNews_com for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for SAGE provided by MarketBeat
In the thread Trading Sage Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Sage Therapeutics Inc.
Stopped prediction by StockNews_com for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€18.10
20.08.23
20.08.23
-
20.08.24
20.08.24
-58.06%
21.08.24
21.08.24
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€20.40
12.08.23
12.08.23
-
12.08.24
12.08.24
-63.58%
13.08.24
13.08.24